Literature DB >> 14637279

Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia.

Nuri Bakan1, Seyithan Taysi, Omer Yilmaz, Ebubekir Bakan, Sevinç Kuşkay, Naim Uzun, Mehmet Gündoğdu.   

Abstract

BACKGROUND: Chronic lymphocytic leukemia (CLL) is a rare neoplasm that comprises a substantial proportion of all leukemias in middle-aged persons and is the most common type among elderly persons. The major causes are not known nor is there a detailed understanding about how the elusive origin(s) may relate to clinical expression, basic biological mechanisms, or pathogenesis.
METHODS: Glutathione peroxidase (GSH-Px), glutathione reductase (GRD), Cu-Zn superoxide dismutase (Cu-Zn SOD) activities, glutathione (GSH), nitric oxide (NO(*), and malondialdehyde (MDA) concentrations were measured in serum of patients with CLL and a healthy control group.
RESULTS: Serum GSH-Px, Cu-Zn SOD activities, GSH concentration were lower in patients with CLL while serum NO(*) and MDA concentrations were higher in these patients compared with the control group. Serum GRD activity was not statistically significant in patients with CLL compared with the control. However, there was no statistically significant difference in the parameters on the basis of stages in these patients. Serum GSH concentration negatively correlated with serum MDA (r=30.63, p<0.05) and NO(*) concentrations (r=0.72, p<0.05) in patients with advanced stage (III+IV). However, no other correlation could be found among the parameters in healthy controls and patients with CLL
CONCLUSIONS: There is significant changes in antioxidant defense system in CLL cases, which may lead to enhanced action of oxygen radical, resulting in lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637279     DOI: 10.1016/j.cccn.2003.08.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.

Authors:  Sabyasachi Biswas; Xiaobin Zhao; Andrew P Mone; Xiaokui Mo; Melissa Vargo; David Jarjoura; John C Byrd; Natarajan Muthusamy
Journal:  Leuk Res       Date:  2010-02-19       Impact factor: 3.156

2.  Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.

Authors:  Hao Daniel Lin; Chui Yee Fong; Arijit Biswas; Mahesh Choolani; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

3.  Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.

Authors:  Mahmoud Abouraya; James C Sacco; Brad S Kahl; Lauren A Trepanier
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

Review 4.  Mitochondrial subversion in cancer.

Authors:  Aditi Chatterjee; Santanu Dasgupta; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2011-05

5.  Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.

Authors:  Yingjen Jeffrey Wu; Leslie L Muldoon; Dana Thomas Dickey; Seth J Lewin; Csanad G Varallyay; Edward A Neuwelt
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

6.  Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.

Authors:  Olaf Merkel; Christoph Heyder; Daniela Asslaber; Frank Hamacher; Inge Tinhofer; Claudia Holler; Markus Stöcher; Andreas Prokesch; Christine Papak; Marcel Scheideler; Zlatko Trajanoski; Richard Greil
Journal:  J Mol Med (Berl)       Date:  2008-02-23       Impact factor: 4.599

7.  Oxidative stress and antioxidant status in patients with chronic myeloid leukemia.

Authors:  Rizwan Ahmad; Anil K Tripathi; Payal Tripathi; Ranjana Singh; Sushma Singh; Raj K Singh
Journal:  Indian J Clin Biochem       Date:  2008-12-20

8.  Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease.

Authors:  Seyithan Taysi; Refik Ali Sari; Hakan Dursun; Adnan Yilmaz; Mustafa Keles; Kerim Cayir; Mehmet Akyuz; Abdullah Uyanik; Adem Guvenc
Journal:  Clin Rheumatol       Date:  2008-07-18       Impact factor: 2.980

9.  Assessment of oxidative stress and inflammatory process in patients of multiple myeloma.

Authors:  Moushumi Lodh; Binita Goswami; Nikhil Gupta; Surajeet K Patra; Alpana Saxena
Journal:  Indian J Clin Biochem       Date:  2012-05-12

10.  Genetic polymorphism of antioxidant enzymes in eosinophilic and non-eosinophilic nasal polyposis.

Authors:  Abdulvahap Akyigit; Erol Keles; Ebru Onalan Etem; Ibrahim Ozercan; Hatice Akyol; Oner Sakallioglu; Turgut Karlidag; Cahit Polat; Irfan Kaygusuz; Sinasi Yalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-11       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.